REPORTED SIGNALS
copper peptide
GHK-Cu
Registration status unknownCompoundinglongevity
0
reports (FAERS)
0.0%
reported as serious
0
signals above threshold
2026-07
last updated
TIMELINE · FDA MILESTONES
Class II recall
2025
Class II recall
2020
2015
2026
SIGNAL RANKING · ROR
What stands out in the reports.
Geen disproportionele signalen met voldoende data om te plotten. Dit kan betekenen dat het middel te weinig meldingen heeft, of dat gemelde effecten in lijn zijn met de achtergrondfrequentie.
INTERPRETATION
Duiding nog niet beschikbaar — wordt automatisch gegenereerd.
LABEL VERSUS REPORT
On the label
No signals currently mapped to the label.
Newly reported
No novel signals above threshold.
REPORTS OVER TIME
Report volume per quarter.
20182019202020212023
RECALL HISTORY · 2 ON RECORD
| Date | Class | Reason | Firm |
|---|---|---|---|
| Jul 30, 2025 | II | Lack of Assurance of Sterility | GenoGenix LLC |
| Nov 30, 2020 | II | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile. | Advanced Nutriceuticals, LLC |
Class I = reasonable probability of serious harm · Class II = temporary or reversible · Class III = unlikely to cause harm. Source: openFDA enforcement.
COMPARE WITHIN LONGEVITY
BRON & CITATIE
HealthProves. copper peptide — reported signals. Retrieved 2026-07-04. Source: openFDA (FAERS). healthproves.com/copper-peptide/
FAERS0 records
Opgehaald2026-07-04
MethodeROR / disproportionaliteit